Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 125 results.
User Information
Export Records
  1. 1.   MoMo30 Binds to SARS-CoV-2 Spike Variants and Blocks Infection by SARS-CoV-2 Pseudovirus
  2. DeBarros, Kenya; Khan, Mahfuz; Coleman, Morgan; Bond, Vincent C; Floyd, Virginia; Gbodossou, Erick; Diop, Amad; Krumpe,Lauren; O'Keefe,Barry; Powell, Michael D
  3. Viruses. 2024, Sep 07; 16(9):
  1. 2.   Advancements in Nanoparticle Characterization
  2. Crist,Rachael; Clogston,Jeffrey; Stern,Steve; Dobrovolskaia,Marina
  3. Methods in Molecular Biology (Clifton, N.J.). 2024 2789: 3-17.
  1. 3.   Pharmacodynamic effects of the PARP inhibitor talazoparib (MDV3800, BMN 673) in patients with BRCA-mutated advanced solid tumors
  2. Mittra, Arjun; Coyne, Geraldine H O' Sullivan; Zlott, Jennifer; Kummar, Shivaani; Meehan, Robert; Rubinstein, Lawrence; Juwara,Lamin; Wilsker,Deborah; Ji,Jay; Miller,Brandon; Navas, Tony; Ferry-Galow,Katherine; Voth,Andrea; Chang,Ting-Chia; Jiwani,Shahanawaz; Parchment,Ralph; Doroshow, James H; Chen, Alice P
  3. Cancer Chemotherapy and Pharmacology. 2023, Nov 27;
  1. 4.   Deciphering the key heterocyclic scaffolds in targeting microtubules, kinases and carbonic anhydrases for cancer drug development
  2. Peerzada, Mudasir Nabi; Hamel,Ernest; Bai,Ruoli; Supuran, Claudiu T.; Azam, Amir
  3. Pharmacology & therapeutics. 2021, Sep; 225
  1. 5.   Yuanhuacine Is a Potent and Selective Inhibitor of the Basal-Like 2 Subtype of Triple Negative Breast Cancer with Immunogenic Potential
  2. Fermaintt, Charles S.; Peramuna, Thilini; Cai, Shengxin; Takahashi-Ruiz, Leila; Essif, Jacob Nathaniel; Grant, Corena V.; O'Keefe,Barry; Mooberry, Susan L.; Cichewicz, Robert H.; Risinger, April L.
  3. Cancers. 2021, JUN; 13(11):
  1. 6.   A Systems Chemoproteomic Analysis of Acyl-CoA/Protein Interaction Networks
  2. Levy, Michaella J; Montgomery, David C; Sardiu, Mihaela E; Montano,Jose; Bergholtz, Sarah E; Nance,Kellie; Thorpe,Abbey; Fox,Stephen; Lin, Qishan; Andresson,Thorkell; Florens, Laurence; Washburn, Michael P; Meier,Jordan
  3. Cell chemical biology. 2020, MAR 19; 27(3): 322-+.
  1. 7.   A Systems Pharmacology Approach Uncovers Wogonoside as an Angiogenesis Inhibitor of Triple-Negative Breast Cancer by Targeting Hedgehog Signaling
  2. Huang, Yujie; Fang, Jiansong; Lu, Weiqiang; Wang, Zihao; Wang, Qi; Hou, Yuan; Jiang, Xingwu; Reizes, Ofer; Lathia, Justin; Nussinov,Ruth; Eng, Charis; Cheng, Feixiong
  3. Cell chemical biology. 2019, Aug 15; 26(8): 1143-1158.e.
  1. 8.   Pharmacologic inhibition of dihydroorotate dehydrogenase induces apoptosis and differentiation in acute myeloid leukemia cells
  2. Wu, Dang; Wang, Wanyan; Chen, Wuyan; Lian, Fulin; Lang, Li; Huang, Ying; Xu, Yechun; Zhang, Naixia; Chen, Yinbin; Liu, Mingyao; Nussinov, Ruth; Cheng, Feixiong; Lu, Weiqiang; Huang, Jin
  3. Haematologica. 2018, Aug 31; 103(9): 1472-1483.
  1. 9.   Englerin A Inhibits EWS-FLI1 DNA Binding in Ewing Sarcoma Cells
  2. Caropreso, V.; Darvishi, E.; Turbyville, T. J.; Ratnayake, R.; Grohar, P. J.; McMahon, J. B.; Woldemichael, G. M.
  3. The Journal of biological chemistry. 2016, 6-May; 291(19): 10058-66.
  1. 10.   Configuration-dependent Presentation of Multivalent IL-15:IL-15Ralpha Enhances the Antigen-specific T Cell Response and Anti-tumor Immunity
  2. Hong, E.; Usiskin, I. M.; Bergamaschi, C.; Hanlon, D. J.; Edelson, R. L.; Justesen, S.; Pavlakis, G. N.; Flavell, R. A.; Fahmy, T. M.
  3. The Journal of biological chemistry. 2016, 22-Apr; 291(17): 8931-50.
  1. 11.   High-throughput single-molecule screen for small-molecule perturbation of splicing and transcription kinetics
  2. Day, C. R.; Chen, H.; Coulon, A.; Meier, J. L.; Larson, D. R.
  3. Methods (San Diego, Calif.). 2016, 1-Mar; 96: 59-68.
  1. 12.   Plumbagin, a naphthaquinone derivative induces apoptosis in BRCA 1/2 defective castrate resistant prostate cancer cells as well as prostate cancer stem-like cells
  2. Reshma, R. S.; Sreelatha, K. H.; Somasundaram, V.; Satheesh Kumar, S.; Nadhan, R.; Nair, R. S.; Srinivas, P.
  3. Pharmacological Research. 2016, Mar; 105: 134-45.
  1. 13.   Suppressive oligodeoxynucleotides reduce lung cancer susceptibility in mice with silicosis
  2. Bode, C.; Kinjo, T.; Alvord, W. G.; Klinman, D. M.
  3. Carcinogenesis. 2014, May; 35(5): 1078-83.
  1. 14.   TrkA in vivo function is negatively regulated by ubiquitination
  2. Kiris, E.; Wang, T.; Yanpallewar, S.; Dorsey, S. G.; Becker, J.; Bavari, S.; Palko, M. E.; Coppola, V.; Tessarollo, L.
  3. Journal of Neuroscience. 2014, 12-Mar; 34(11): 4090-8.
  1. 15.   The importance of Raf dimerization in cell signaling
  2. Freeman, A. K.; Ritt, D. A.; Morrison, D. K.
  3. Small GTPases. 2013, Jul-Sep; 4(3): 180-5.
  1. 16.   mRNA and microRNA Expression Profiles of the NCI-60 Integrated with Drug Activities
  2. Liu, H. F.; D'Andrade, P.; Fulmer-Smentek, S.; Lorenzi, P.; Kohn, K. W.; Weinstein, J. N.; Pommier, Y.; Reinhold, W. C.
  3. Molecular Cancer Therapeutics. 2010, May; 9(5): 1080-1091.
  1. 17.   TNF-alpha: an activator of CD4+FoxP3+TNFR2+ regulatory T cells
  2. Chen, X.; Oppenheim, J. J.
  3. Current directions in autoimmunity. 2010 11: 119-34.
  1. 18.   Microbial antitumor drugs: natural products of microbial origin as anticancer agents
  2. Newman, D. J.; Cragg, G. M.
  3. Current Opinion in Investigational Drugs. 2009, Dec; 10(12): 1280-96.
  1. 19.   Therapeutic agents from the sea: biodiversity, chemo-evolutionary insight and advances to the end of Darwin's 200th year
  2. Newman, D. J.; Cragg, G. M.; Battershill, C. N.
  3. Diving and Hyperbaric Medicine. 2009, Dec; 39(4): 216-225.
  1. 20.   Development of HIF-1 inhibitors for cancer therapy
  2. Onnis, B.; Rapisarda, A.; Melillo, G.
  3. Journal of Cellular and Molecular Medicine. 2009, Sep; 13(9A): 2780-6.
  1. 21.   Synthesis and conformational analysis of locked carbocyclic analogues of 1,3-diazepinone riboside, a high-affinity cytidine deaminase inhibitor
  2. Ludek, O. R.; Schroeder, G. K.; Liao, C.; Russ, P. L.; Wolfenden, R.; Marquez, V. E.
  3. Journal of Organic Chemistry. 2009, Aug 21; 74(16): 6212-23.
  1. 22.   Cytotoxic and HIF-1alpha inhibitory compounds from Crossosoma bigelovii
  2. Klausmeyer, P.; Zhou, Q.; Scudiero, D. A.; Uranchimeg, B.; Melillo, G.; Cardellina, J. H.; Shoemaker, R. H.; Chang, C. J.; McCloud, T. G.
  3. Journal of Natural Products. 2009, May 22; 72(5): 805-12.
  1. 23.   Anti-HIV-1 therapeutics: from FDA-approved drugs to hypothetical future targets
  2. Adamson, C. S.; Freed, E. O.
  3. Molecular Interventions. 2009, Apr; 9(2): 70-4.
  1. 24.   Quassinoid inhibition of AP-1 function does not correlate with cytotoxicity or protein synthesis inhibition
  2. Beutler, J. A.; Kang, M. I.; Robert, F.; Clement, J. A.; Pelletier, J.; Colburn, N. H.; McKee, T. C.; Goncharova, E.; McMahon, J. B.; Henrich, C. J.
  3. Journal of Natural Products. 2009, Mar 27; 72(3): 503-6.
  1. 25.   Inhibitors of the NF-kappaB activation pathway from Cryptocarya rugulosa
  2. Meragelman, T. L.; Scudiero, D. A.; Davis, R. E.; Staudt, L. M.; McCloud, T. G.; Cardellina, J. H. 2nd.; Shoemaker, R. H.
  3. Journal of Natural Products. 2009, Mar 27; 72(3): 336-9.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel